BRA
ARNA

Blue Rock Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Blue Rock Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-31,780
Closed -$2.38M – 106
2020
Q3 		$2.38M Buy
+31,780
New +$2.12M 2.05% 8

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Blue Rock Advisors's ARNA Position: Q4 2020 in Review

Blue Rock Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2020, closing a stake of 31,780 shares — an estimated $2.38M sold.

Blue Rock Advisors first reported a position in ARNA in Q3 2020 and held it in 1 quarter. The position peaked at $2.38M in Q3 2020. 254 funds tracked by Wall St. Rank hold ARNA as of Q4 2020.

  • Blue Rock Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q4 2020 after selling out during the quarter.
  • Blue Rock Advisors sold 31,780 Arena Pharmaceuticals Inc shares in Q4 2020, an estimated $2.38M.
  • Blue Rock Advisors first reported a position in Arena Pharmaceuticals Inc in Q3 2020 and held it in 1 quarter.
  • Blue Rock Advisors's Arena Pharmaceuticals Inc position peaked at $2.38M in Q3 2020.
  • 254 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2020.

Based on Blue Rock Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.